Celcuity Inc. Schedules Release of Third Quarter 2021 Financial Results and Webcast/Conference Call

Rhea-AI Summary

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company, announced it will release its third quarter 2021 financial results on November 8, 2021, after the market closes. A webcast and teleconference will follow at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update. The company focuses on extending cancer patients' lives through an integrated companion diagnostic and therapeutic strategy, utilizing its CELsignia platform to identify patients likely to benefit from targeted therapies.

Positive

• Celcuity's CELsignia platform analyzes live tumor cells, enhancing targeted therapy identification.
• Company is pursuing an integrated diagnostic and therapeutic strategy for cancer treatment.

Negative

• None.

MINNEAPOLIS, MN / ACCESSWIRE / October 29, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated companion diagnostic and therapeutic strategy for treating patients with cancer, today announced that it will release its financial results for the third quarter 2021 after the stock market close on Monday, November 8, 2021. Management will host a webcast/teleconference the same day at 4:30 p.m. Eastern Time to discuss the results and provide a corporate update.

Webcast and Conference Call Information

To participate in the teleconference, domestic callers should dial 1-877-407-0784 and international callers should dial 1-201-689-8560 and reference conference ID: 13724062. A live webcast presentation can also be accessed using this weblink: https://78449.themediaframe.com/dataconf/productusers/vvdb/mediaframe/46959/indexl.html. A replay of the webcast will be available on the Celcuity website following the live event.

About Celcuity

Celcuity is a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic and therapeutic strategy. Its CELsignia companion diagnostic platform is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from already approved targeted therapies. Its therapeutic efforts are focused on in-licensing and developing molecularly targeted therapies that address the same cancer driver its companion diagnostics can identify. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com.

Contacts:

Celcuity Inc.
Brian Sullivan, bsullivan@celcuity.com
Vicky Hahne, vhahne@celcuity.com

ICR Westwicke
Robert Uhl, robert.uhl@westwicke.com
(619) 228-5886

SOURCE: Celcuity Inc.

View source version on accesswire.com:
https://www.accesswire.com/670329/Celcuity-Inc-Schedules-Release-of-Third-Quarter-2021-Financial-Results-and-WebcastConference-Call

FAQ

When will Celcuity release its third quarter 2021 financial results?

Celcuity will release its third quarter 2021 financial results on November 8, 2021.

What time is Celcuity's webcast for third quarter financial results?

The webcast for Celcuity's third quarter financial results will be at 4:30 p.m. Eastern Time on November 8, 2021.

What is Celcuity's main focus in the biotechnology sector?

Celcuity focuses on developing companion diagnostics and targeted therapies for cancer patients.